Navigation Links
Noted Vertebroplasty Expert Cites Concerns About Recently Published Study
Date:8/11/2009

Dr. Mubin Syed evaluates findings; calls for additional research

DAYTON, Ohio, Aug. 11 /PRNewswire/ -- A new study by Mayo Clinic researchers has given rise to more questions than answers about the effectiveness of vertebroplasty to treat osteoporotic spinal fractures.

Vertebroplasty is a widely used procedure in which medical cement is injected into vertebrae to relieve pain and improve mobility in patients who have osteoporotic fractures. This study, funded by the National Institutes of Health, was the first of its kind, using a double-blinded research model to examine the impact of vertebroplasty. It was published last week in The New England Journal of Medicine to mixed reviews by the medical community.

"This was an extremely interesting study, but the results are far from conclusive due to several weaknesses in the method used. Additional research is definitely indicated," said Dr. Mubin I. Syed, a neuroradiologist and diagnostic, interventional and vascular radiologist.

One major issue cited by Dr. Syed was the small size of the study group. To demonstrate statistical differences between groups requires that the research team enroll enough patients for the statistics to have meaning. The original group size for the Mayo Clinic study was to be 250 patients. Due to difficulties in recruiting participants, the final group size was reduced to 131 people, nearly half of the original design.

"This is important," explained Dr. Syed, "because the trends in the data show that if the study had enough patients, the group receiving vertebroplasty could have demonstrated a clinically meaningful improvement in pain. It is therefore surprising that a study that was showing a trend toward statistical significance was terminated early with only half the number of patients recruited. A huge doubt now remains as to whether a study with the original i
'/>"/>

SOURCE Dr. Mubin I. Syed
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Signs of Depression Noted in Second Graders
2. UPDATE: Swine Flu Spread Will Trigger Difficult Legal Questions for Employers Says Noted Pillsbury Attorney
3. Swine Flu Plans Triggering Difficult Legal Questions, Says Noted Pillsbury Attorney
4. Kouros Azar, M.D. (doctorazar.com), Noted Plastic and Reconstructive Surgeon, Offers Top 10 Tips to Patients to Help Celebrate National Patient Safety Awareness Week
5. Noted State Government Medical Director Dr. Stephen Saunders To Join APS Healthcare
6. Three Noted Women of Valor to be Honored at Los Angeles Jewish Home Gala Dinner
7. 4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists
8. Noted Litigator Peter Diedrich Joins Musick Peeler & Garrett LLP
9. 39 Noted Performing Artists Urge Congress to Fix Flaws in Presidents Global AIDS Plan
10. Los Angeles Jewish Home Support Group Continues High-Profile Speaker Program With Noted Legal Scholar and Expert Laurie L. Levenson
11. Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading: Studies Actually Show it is Effective at Reducing Pain

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ov.24/PRNewswire/--Mostpeoplelookforwardtokickingo...getherwithfriendsandfamily.TheMacombCountyHealthDe...gtheholidays.Travelingandbeinginlargegroupsareeasy...ayhealthy: ,, VACCINATION ,, Thefirstandmo...togetvaccinatedagainsttheH1N1strainoftheflu.TheMac...
(Date:11/24/2009)...f.,Nov.24/PRNewswire/--Nextmonth,UnitedHealthcarew...pingHispanic-AmericanseniorsunderstandthebasicsofM...takeafreeZumba®Goldclass,aLatin-infusedfitnes...a,rumba,andtango. ,, UnitedHealthcarewilloffert...andengagedwhenlearningabouttheirhealthcareoptions....
(Date:11/24/2009)...Newswire-FirstCall/--CenteneCorporation(NYSE: CNC ...dhasselectedCenteneasoneoftwoCoordinatedCareOrgani...essNetwork(MississippiCAN),acoordinatedcareprogram...ngwiththeDivisiontoexecuteacontractinwhichthecompa...noliaHealthPlan(Magnolia). ,, BasedinJackson,Mi...
(Date:11/24/2009)...the falls that plague older adults, study finds, ... Falls are a leading cause of death among older Am...in contributes to those accidents. , "Pain cont... and is associated with mobility limitations that .... , "Chronic pain, no matter how we measured it...
(Date:11/24/2009)...ewswire-USNewswire/--TheAmericanDentalAssociation(...nnewdentalteammembersaspartofapilotprogramtoimprov...ommunityDentalHealthCoordinator(CDHC)isamemberofth...tshavelimitedaccesstodentalcaretoimprovetheiroralh...ivedentalcareservices--includingscreeningsandfluor...
Breaking Medicine News(10 mins):Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Chronic Pain Trips Up Seniors 2Health News:Chronic Pain Trips Up Seniors 3Health News:ADA Launches Community Dental Health Coordinator Pilot Program at Temple University 2
...iscovery including solutions to tackle obesity, t...r and issues surrounding drugs used in sport and t...n Brighton next week. , The British Pharmacologic...ss the world. , Running from 16 to 18 December, t...
...Board of Medical Specialties (ABMS), the organizat...ialists in the United States, has appointed Richar...professional and scientific affairs. Hawkins will ...promote the science of ABMS Maintenance of Certifi...
...harmaceutical Companies, Inc. (NYSE: PRX ) today..., executive vice president and chief financial off...fessional opportunities. , , Lawrence A. Ke... Mr. Kenyon joins from Alfacell Corporation where ...
...ber 8, 2008, TooBusyWorking was launched as a next...s local nursing job openings from all major employ...has more local nursing job listings than CareerBui...s with information detailing commuting distance, s...
... malaria elimination can be achieved. A supplement...of articles reviewing the many aspects of the rese... of the supplement,s reviews charts the progress t...ferent vaccine strategy, since success will depend...
...rporation and Terumo,s,subsidiary, Terumo Cardiova...hey have entered into an agreement to settle all o...LLC. The companies have a number of lawsuits pend...All pending,disputes between the companies will be...
Other Medicine News:Health News:Leading pharmacologists to meet in Brighton 2Health News: ABMS Appoints Richard Hawkins, MD, FACP as New Senior Vice President for Professional and Scientific Affairs 2Health News: ABMS Appoints Richard Hawkins, MD, FACP as New Senior Vice President for Professional and Scientific Affairs 3Health News:Par Pharmaceutical Announces the Resignation of Its Chief Financial Officer 2Health News:Malaria Journal supplement evaluates steps toward elimination 2
(Date:11/24/2009)...ov.24/PRNewswire/--ZargisMedicalCorp.,asubsidiaryo...sCorporateResearch(NYSE: SI ),todayannouncedthatit...2009episodeofCBS, TheEarlyShow duringasegmentinwhi...eviewedfivewinningproductsfromthepublication,s2009...dely-viewedtelevisionmorningnewstalkshowbroadcastb...
(Date:11/24/2009)...PRNewswire/--AmbitBiosciencesCorporationannouncedt...AC220,anovelsecondgenerationFLT3inhibitor,inAMLatt...)tobeheldinNewOrleans,LA,December5-8,2009.Anoralpr...lPhaseImonotherapysafetystudyinadultswithacutemyel...bepresentedevaluatingtheeffectofAC220monotherapyan...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--EchoTherapeutics,Inc....e-freeSymphony(TM)tCGMSystemasanon-invasive,wirele...temanditsPrelude(TM)SkinPrepSystemfortransdermaldr...ChairmanandChiefExecutiveOfficer,willpresentatthe1...nce,sponsoredbytheNewYorkSocietyofSecuritiesAnalys...
Breaking Medicine Technology:Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 1Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 2Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 3YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 1YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 2YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 3YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG 14651 4Beckman Coulter Announces Third Quarter 2009 Results 5858 1Beckman Coulter Announces Third Quarter 2009 Results 5858 2Beckman Coulter Announces Third Quarter 2009 Results 5858 3Beckman Coulter Announces Third Quarter 2009 Results 5858 4Beckman Coulter Announces Third Quarter 2009 Results 5858 5Beckman Coulter Announces Third Quarter 2009 Results 5858 6Beckman Coulter Announces Third Quarter 2009 Results 5858 7Beckman Coulter Announces Third Quarter 2009 Results 5858 8Beckman Coulter Announces Third Quarter 2009 Results 5858 9Beckman Coulter Announces Third Quarter 2009 Results 5858 10Beckman Coulter Announces Third Quarter 2009 Results 5858 11Beckman Coulter Announces Third Quarter 2009 Results 5858 12Beckman Coulter Announces Third Quarter 2009 Results 5858 13Beckman Coulter Announces Third Quarter 2009 Results 5858 14Beckman Coulter Announces Third Quarter 2009 Results 5858 15Beckman Coulter Announces Third Quarter 2009 Results 5858 16Beckman Coulter Announces Third Quarter 2009 Results 5858 17Beckman Coulter Announces Third Quarter 2009 Results 5858 18Beckman Coulter Announces Third Quarter 2009 Results 5858 19Beckman Coulter Announces Third Quarter 2009 Results 5858 20Beckman Coulter Announces Third Quarter 2009 Results 5858 21Beckman Coulter Announces Third Quarter 2009 Results 5858 22Beckman Coulter Announces Third Quarter 2009 Results 5858 23Beckman Coulter Announces Third Quarter 2009 Results 5858 24Beckman Coulter Announces Third Quarter 2009 Results 5858 25Beckman Coulter Announces Third Quarter 2009 Results 5858 26Beckman Coulter Announces Third Quarter 2009 Results 5858 27Beckman Coulter Announces Third Quarter 2009 Results 5858 28Beckman Coulter Announces Third Quarter 2009 Results 5858 29Beckman Coulter Announces Third Quarter 2009 Results 5858 30Beckman Coulter Announces Third Quarter 2009 Results 5858 31Beckman Coulter Announces Third Quarter 2009 Results 5858 32Beckman Coulter Announces Third Quarter 2009 Results 5858 33Beckman Coulter Announces Third Quarter 2009 Results 5858 34Beckman Coulter Announces Third Quarter 2009 Results 5858 35
Standard Light Source 650.2
...nsists of two plastic parts that clamp a corneal g... cornea like a standard graft. The Boston Keratopr...s and has gradually been perfected. It received FD...been performed. It is the most commonly used kerat...
STAT E&M Coder
STAT ICD-9 Coder
Medicine Products: